Silver Book Fact
A current drug in development addresses the underlying cause of type 2 diabetes by modulating genes responsible for insulin sensitization.
PhRMA. 2008 Report: Medicines in Development for Older Americans; November 2008
A current drug in development addresses the underlying cause of type 2 diabetes by modulating genes responsible for insulin sensitization.
PhRMA. 2008 Report: Medicines in Development for Older Americans; November 2008